Optimi Health Announces Investor Relations Agreement

VANCOUVER, British Columbia, March 08, 2022 — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional and novel psychedelic compounds for the health and...

Optimi Health Upgrades Trading to the OTCQX Best Market

VANCOUVER, BC (March 1, 2022) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional and novel psychedelic compounds for the health and wellness sector, is...
OptimiTM

Sign up for free News Alerts